A compact and simple method of achieving differential transgene expression by exploiting translational readthrough

Area of Science:

• Molecular Biology
• Gene Therapy
• Bioengineering

Background:

• Multicistronic vectors are crucial for gene therapy, but their limited packaging capacity hinders the insertion of long regulatory sequences.
• Achieving differential transgene expression is essential but challenging with current methods.

Purpose of the Study:

• To develop a compact and efficient method for achieving differential transgene expression in multicistronic vectors.
• To demonstrate the utility of translational readthrough motifs (TRMs) for controlling gene expression levels.

Main Methods:

• Insertion of stop codons and translational readthrough motifs (TRMs) into multicistronic vectors to suppress stop codon termination.
• Quantification of downstream transgene expression levels modulated by different stop codon and TRM combinations.
• In vivo testing of TRM-mediated IL-12 secretion in a mouse melanoma model.

Main Results:

• TRMs effectively reduced downstream transgene expression by approximately sixfold to 140-fold.
• Controlled secretion of the cytokine IL-12 was achieved at therapeutically beneficial levels.
• TRM application in a mouse melanoma model demonstrated prevention of tumor growth.

Conclusions:

• TRMs offer a simple, compact (6 bp), and easily introducible method for differential transgene expression.
• This technology has broad applications in recombinant DNA engineering and gene therapy.
• TRMs facilitate controlled therapeutic protein secretion, showing promise for cancer treatment.